Nina Tyutyusheva

Dr. Nina Tyutyusheva


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NTNina Tyutyusheva
Nina Tyutyusheva
IMIlaria Mancini
Ilaria Mancini
GBGiampiero Igli Baroncelli
Giampiero Igli Baroncelli
SDSofia D’elios
Sofia D’elios
DPDIEGO PERONI
DIEGO PERONI
Silvano BertelloniSilvano Bertelloni
Silvano Bertelloni
Complete androgen insensitivity syndrome (CAIS) is due to complete resistance to the action of androgens, determining a female phenotype in persons with a 46,XY karyotype and functioning testes. CAIS is caused by inactivating mutations in the androgen receptor gene (AR). It is organized in eight exons located on the X chromosome. Hundreds of genetic variants in the AR gene have been reported in CAIS. They are distributed throughout the gene with a preponderance located in the ligand-binding domain. CAIS mainly presents as primary amenorrhea in an adolescent female or as a bilateral inguinal/labial hernia containing testes in prepubertal children. Some issues regarding the management of females with CAIS remain poorly standardized (such as the follow-up of intact testes, the timing of gonadal removal and optimal hormone replacement therapy). Basic research will lead to the consideration of new issues to improve long-term well-being (such as bone health, immune and metabolic aspects and cardiovascular risk). An expert multidisciplinary approach is mandatory to increase the long-term quality of life of women with CAIS.

6 May 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
GCGiorgio Costagliola
Giorgio Costagliola
MCM. Cosci o di Coscio
M. Cosci o di Coscio
BMB. Masini
B. Masini
FBFulvia baldinotti
Fulvia baldinotti
Maria CaligoMaria Caligo
Maria Caligo
Silvano BertelloniSilvano Bertelloni
Silvano Bertelloni

15 March 2021 in Sexes
Verified
Journal Article
Open access
PDF file
CMCristina Mucaria
Cristina Mucaria
NTNina Tyutyusheva
Nina Tyutyusheva
GBGiampiero I. Baroncelli
Giampiero I. Baroncelli
DPDIEGO PERONI
DIEGO PERONI
Silvano BertelloniSilvano Bertelloni
Silvano Bertelloni
Central precocious puberty (CPP) is due to the premature activation of the hypothalamic–pituitary–gonadal axis, which is responsible for the appearance of secondary sexual characteristics. It occurs before the age of 8 and 9 in girls and boys, respectively. CPP shows higher incidence in females than in males. Causes of CPP are similar in both sexes, but the idiopathic form is more frequent in girls, while organic forms are more frequent in males. Recent studies demonstrated a role of some genetic variants in the pathogenesis of CPP. The diagnostic evaluation based on accurate physical examination, assessment of the pituitary–gonadal axis, pelvic sonography in girls, and determination of bone age. Magnetic resonance of the central nervous system should be done in all boys and selected girls. Since the 1980s, pharmacologic treatment involves the use of gonadotropin-releasing hormone (GnRH) analogs. These drugs are characterized by few side effects and long-term safety. Many data are available on the outcome of GnRH analog treated female patients, while poor data are reported in boys. Adult height is improved in both sexes.

29 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
AOAlessandro Orsini
Alessandro Orsini
ASAndrea Santangelo
Andrea Santangelo
ACAlessandra Carmignani
Alessandra Carmignani
ACAnna Camporeale
Anna Camporeale
FMFrancesco Massart
Francesco Massart
ABAlice Bonuccelli
Alice Bonuccelli
The adaptor protein 4 (AP-4) constitutes a conserved hetero-tetrameric complex within the family of adaptor protein (AP) complex, crucial for the signal-mediated trafficking of integral membrane proteins. Mutations affecting all subunits of the AP-4 complex have been linked to autosomal-recessive cerebral palsy and a complex hereditary spastic paraparesis (HSP) phenotype. Our report details the case of a 14-year-old boy born to consanguineous parents, presenting psychomotor delay, severe intellectual disability, microcephaly, and trigonocephaly. Despite a history of febrile seizures, subsequent years were devoid of seizures, with normal EEG. Exome sequencing revealed pathogenic variants in both the AP4B1 and ERF genes. Significantly, the patient exhibited features associated with AP4B1 mutations, including distinctive traits such as cranial malformations. The ERF gene variant, linked to craniosynostosis, likely contributes to the observed trigonocephaly. This case represents the initial documentation of a concurrent mutation in the AP4B1 and ERF genes, underscoring the critical role of exome analysis in unraveling complex phenotypes. Understanding these complex genotypes offers valuable insights into broader syndromic conditions, facilitating comprehensive patient management.

25 September 2023 in Sexes
Verified
Journal Article
Open access
PDF file
GBGiulia Bertolucci
Giulia Bertolucci
NTNina Tyutyusheva
Nina Tyutyusheva
MSMargherita Sepich
Margherita Sepich
FBFulvia baldinotti
Fulvia baldinotti
Maria CaligoMaria Caligo
Maria Caligo
Silvano BertelloniSilvano Bertelloni
Silvano Bertelloni
Congenital adrenal hyperplasia (CAH) is a heterogeneous group of autosomal recessive disorders due to defects in adrenal steroid biosynthesis. In about 90% of patients, CAH is caused by pathogenetic variants in CYP21A2 gene, impairing the function of 21-hydroxylase (21-OH) enzyme. CAH can present as classical form (simple virilizing or salt wasting) or as non-classical form (NC-CAH). NC-CAH is due to pathogenetic variants in the CYP21A2 gene that result in 20–70% residual activity of 21-hydroxylase. Early diagnosis may be missed, mainly in childhood, jeopardizing long-term outcome. This paper will review some information on clinical findings, symptoms, diagnostic approaches, and treatments of NC-CAH in childhood, allowing better management and long-term outcome.